RXO, Inc. (RXO) PT Lowered to $13 at JPMorgan

April 7, 2026 7:39 AM

JPMorgan analyst Brian Ossenbeck lowered the price target on RXO, Inc. (NYSE: RXO) to $13.00 (from $14.00) while maintaining a Underweight rating.

No results found